Published in J Med Genet on October 01, 2000
A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am J Hum Genet (2003) 5.34
Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J Med Genet (2003) 1.92
Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. J Cell Biol (2005) 1.80
ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet (2006) 1.59
Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet (2001) 1.40
Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine. J Clin Invest (2005) 1.39
Genomewide linkage searches for Mendelian disease loci can be efficiently conducted using high-density SNP genotyping arrays. Nucleic Acids Res (2004) 1.37
Hereditary spastic paraplegia SPG4: what is known and not known about the disease. Brain (2015) 1.28
Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia. Eur J Hum Genet (2008) 1.20
Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics (2004) 1.19
Spastin, the most commonly mutated protein in hereditary spastic paraplegia interacts with Reticulon 1 an endoplasmic reticulum protein. Neurogenetics (2006) 1.15
Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology. Hum Genet (2015) 1.09
Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet (2005) 1.01
A cryptic promoter in the first exon of the SPG4 gene directs the synthesis of the 60-kDa spastin isoform. BMC Biol (2008) 0.98
Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia. Clin Genet (2011) 0.95
Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses. J Hum Genet (2014) 0.92
Evaluation of loss of function as an explanation for SPG4-based hereditary spastic paraplegia. Hum Mol Genet (2010) 0.91
Motor system abnormalities in hereditary spastic paraparesis type 4 (SPG4) depend on the type of mutation in the spastin gene. J Neurol Neurosurg Psychiatry (2003) 0.87
Congenital bovine spinal dysmyelination is caused by a missense mutation in the SPAST gene. Neurogenetics (2009) 0.86
Mutation analysis of SPAST, ATL1, and REEP1 in Korean Patients with Hereditary Spastic Paraplegia. J Clin Neurol (2014) 0.83
Pathogenic mutation of spastin has gain-of-function effects on microtubule dynamics. J Neurosci (2014) 0.80
Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family. Neurogenetics (2010) 0.79
Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations. J Neurol (2015) 0.77
A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes. Neurogenetics (2012) 0.76
Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements. BMC Neurol (2010) 0.76
Quantitative Gait Analysis Using a Motorized Treadmill System Sensitively Detects Motor Abnormalities in Mice Expressing ATPase Defective Spastin. PLoS One (2016) 0.76
Modeling Axonal Defects in Hereditary Spastic Paraplegia with Human Pluripotent Stem Cells. Front Biol (Beijing) (2016) 0.75
No correlation between amount of aberrant transcript and severity of phenotype in hereditary spastic paraplegia patients with a c.1242A > G splice mutation in the SPG4 gene. J Neurol (2005) 0.75
Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet (1999) 4.74
Classification of the hereditary ataxias and paraplegias. Lancet (1983) 4.44
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 4.41
The AAA team: related ATPases with diverse functions. Trends Cell Biol (1998) 3.48
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40
X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet (1994) 1.97
Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.82
Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology (1999) 1.72
Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. Nat Genet (1993) 1.60
Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. Am J Hum Genet (1995) 1.52
Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology (1996) 1.50
Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. Hum Mol Genet (1994) 1.49
Hereditary spastic paraplegias. Semin Neurol (1993) 1.44
Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q. Neurology (1999) 1.33
Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes. Am J Hum Genet (1999) 1.32
Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet (1994) 1.29
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet (1998) 1.25
Mutations in connexin31 underlie recessive as well as dominant non-syndromic hearing loss. Hum Mol Genet (2000) 1.15
Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet (1999) 1.06
Locus-phenotype correlations in autosomal dominant pure hereditary spastic paraplegia. A clinical and molecular genetic study of 28 United Kingdom families. Brain (1999) 1.03
A fine integrated map of the SPG4 locus excludes an expanded CAG repeat in chromosome 2p-linked autosomal dominant spastic paraplegia. Genomics (1999) 0.81
A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
The absorption of glucose from the alimentary canal. J Physiol (1931) 7.84
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97
Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ (2009) 2.85
Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ (2008) 2.65
Sequence and structure of yeast phosphoglycerate kinase. EMBO J (1982) 2.64
Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet (1999) 2.49
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol (1999) 2.29
Microsatellites show mutational bias and heterozygote instability. Nat Genet (1996) 2.18
Dynamic reorientation of cortical microtubules, from transverse to longitudinal, in living plant cells. Proc Natl Acad Sci U S A (1994) 2.17
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology (2006) 2.00
A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods (1986) 1.98
Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol (1998) 1.97
An actin network is present in the cytoplasm throughout the cell cycle of carrot cells and associates with the dividing nucleus. J Cell Biol (1987) 1.96
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93
A molecular investigation of true dominance in Huntington's disease. J Med Genet (1999) 1.92
Network analysis of human Y microsatellite haplotypes. Hum Mol Genet (1996) 1.89
Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A (2000) 1.88
A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet (1991) 1.88
Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain (1998) 1.84
Association of phosphatidylinositol 3-kinase with nuclear transcription sites in higher plants. Plant Cell (2000) 1.81
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet (2001) 1.81
A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet (1999) 1.79
Early neurological complications of coronary artery bypass surgery. Br Med J (Clin Res Ed) (1985) 1.78
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology (2003) 1.78
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2001) 1.74
Microinjected profilin affects cytoplasmic streaming in plant cells by rapidly depolymerizing actin microfilaments. Curr Biol (1994) 1.70
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Improved outcomes of children with malignancy admitted to a pediatric intensive care unit. Crit Care Med (2000) 1.69
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Clusters of multiple different small nucleolar RNA genes in plants are expressed as and processed from polycistronic pre-snoRNAs. EMBO J (1997) 1.66
An empirical exploration of the (delta mu)2 genetic distance for 213 human microsatellite markers. Am J Hum Genet (1999) 1.66
Conservative treatment of delayed cerebral radiation necrosis. J Neurol Neurosurg Psychiatry (1984) 1.66
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.65
Predicting death from initial disease severity in very low birthweight infants: a method for comparing the performance of neonatal units. BMJ (1990) 1.63
Bone-marrow transplantation for leukaemia. Lancet (1995) 1.62
Transcription sites are not correlated with chromosome territories in wheat nuclei. J Cell Biol (1998) 1.61
An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry (2010) 1.60
The movement of coiled bodies visualized in living plant cells by the green fluorescent protein. Mol Biol Cell (1999) 1.59
Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J Med Genet (1998) 1.57
The organization of spliceosomal components in the nuclei of higher plants. J Cell Sci (1995) 1.55
Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disord (1997) 1.49
Determination of ephedrine-type alkaloids in dietary supplements by LC/MS using a stable-isotope labeled internal standard. J AOAC Int (2001) 1.49
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol (1999) 1.46
Acute myeloid leukaemia in patients with trisomy 21 (Down syndrome) treated by bone marrow transplantation. J Paediatr Child Health (1994) 1.46
Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics (1991) 1.46
Non-invasive ventilation in motor neuron disease: current UK practice. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 1.44
Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) (2005) 1.43
Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ (2007) 1.41
Three-dimensional architecture of the cell sheath and septa of Methanospirillum hungatei. J Bacteriol (1985) 1.40
Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking. Chest (1983) 1.40
Coiled body numbers in the Arabidopsis root epidermis are regulated by cell type, developmental stage and cell cycle parameters. J Cell Sci (1998) 1.40
Sleep and the fruit fly. Trends Neurosci (2001) 1.39
A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2p. Hum Mol Genet (1994) 1.38
Autosomal dominant retinitis pigmentosa: absence of the rhodopsin proline----histidine substitution (codon 23) in pedigrees from Europe. Am J Hum Genet (1990) 1.36
Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology (2000) 1.36
Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology (2003) 1.35
A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nat Genet (1994) 1.35
Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging (2008) 1.35
Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology (2006) 1.35
Cerebral infarction in a young female following snake bite. Stroke (1985) 1.33
Nervous system brucellosis: diagnosis and treatment. Neurology (1985) 1.33
Resolution of the components in the microsomal fraction of liver in the B-IV zonal centrifuge. Natl Cancer Inst Monogr (1966) 1.32
Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet (1999) 1.31
The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer (1997) 1.30
Dynamic behavior of Arabidopsis eIF4A-III, putative core protein of exon junction complex: fast relocation to nucleolus and splicing speckles under hypoxia. Plant Cell (2009) 1.29
Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc Natl Acad Sci U S A (2000) 1.28
Rapid restructuring of bicoid-dependent hunchback promoters within and between Dipteran species: implications for molecular coevolution. Evol Dev (2002) 1.26
Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology (2004) 1.26
European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis (2012) 1.26
Cell wall glycoproteins: structure and function. J Cell Sci Suppl (1985) 1.24
A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet (1995) 1.23
Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol (1998) 1.23
Preparation of a plasma membrane fraction from rat liver by zonal centrifugation. Eur J Biochem (1970) 1.23
Childhood reflux and urinary infection: a follow-up of 10-41 years in 226 adults. Pediatr Nephrol (1998) 1.22
Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord (2000) 1.22
Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. Clin Radiol (2004) 1.22
Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet (1998) 1.20
Linkage to D3S47 (C17) in one large autosomal dominant retinitis pigmentosa family and exclusion in another: confirmation of genetic heterogeneity. Am J Hum Genet (1990) 1.20
Contrast sensitivity during saccadic eye movements. Vision Res (1978) 1.18
Clinical heterogeneity of autosomal recessive spastic paraplegias: analysis of 106 patients in 46 families. Arch Neurol (1999) 1.16
Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis (1995) 1.16
Ascertainment bias cannot entirely account for human microsatellites being longer than their chimpanzee homologues. Hum Mol Genet (1998) 1.16
Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke (1987) 1.16
Markov chain Monte Carlo analysis of human Y-chromosome microsatellites provides evidence of biased mutation. Proc Natl Acad Sci U S A (1999) 1.15